COMPARE · Data as of August 25, 2026
EHC vs PACS
Verdict: Side-by-side breakdown using the Bull Rankings model. EHC scored 68.1, PACS scored 70.6 — PACS leads.
Compare another set
EHC
Encompass Health Corporation
68.1
$120.14 · $11.9B
fundamentals as of
Score gap
2.5
PACS leads
PACS
PACS Group, Inc.
70.6
$43.94 · $7.0B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestEHC20.1x
- Fastest growthPACS+15.2%
- Strongest balance sheetEHC0.82
- Highest qualityEHC68 / 100
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
EHC
stronger →← stronger
PACS
68
Qualityreturns · margins · balance sheet
63
73
Growthrevenue & earnings expansion
90
63
Valuevaluation vs sector peers
62
EHC is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
EHC
PACS
$413mC
FCF
$121mC
+9.5%B
Rev
+15.2%B+
0.82C
D/E
3.05D
20.1xA-
P/E
25.8xB
0.41A
PEG
1.19B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
EHC
PACS
16% above
Price vs fair valuelower is cheaper
250% above
~10%/yr
Growth the price implies10-yr FCF · lower = less priced in
~38%/yr
-21%
1-yr DCF upside
-73%
-14%
5-yr DCF upside
-71%
-2%
10-yr DCF upside
-69%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
EHC
Why this score
- Buying back stock
- Raising its dividend
PACS
Why this score
- Short track record
The companies
EHCEncompass Health Corporation
Why now
Medical Care Facilities · market cap $11.9b. 6% off the 52-week high of $127.99. PEG 0.41 — paying under fair value for the growth rate. 12 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $148.17 (implying +23% upside).
Moat
ROE 24% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
PACSPACS Group, Inc.
Why now
Medical Care Facilities · market cap $7.0b. 11% off the 52-week high of $49.49. Revenue growing +15%, comfortably above the S&P median. 5 sell-side analysts publish a mean 1-yr target of $59.20 (implying +35% upside).
Moat
ROE 24% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
D/E 3.05 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Net margin 4.9% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where EHC and PACS diverge
On the headline score the gap is 2.5 points in favor of PACS. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- GrowthEHC 73.5 · PACS 89.7PACS +16.2
- QualityEHC 68.2 · PACS 62.8EHC +5.4
- ValueEHC 63.1 · PACS 62.4level
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.